Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03418350
Other study ID # HS-3130
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 1, 2018
Est. completion date December 2025

Study information

Verified date September 2022
Source National Jewish Health
Contact Tara Churney, MPH
Phone 303-398-1996
Email ILDresearch@njhealth.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).


Description:

The study team hypothesizes the SGI will correlate more strongly with measures of IPF severity (at baseline and over time) than gastroesophageal reflux (GER) data derived from the esophageal detector channels of a pH/impedance probe.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 2025
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 40 Years to 95 Years
Eligibility Inclusion Criteria: - Diagnosis of IPF - Age 40-95 - Able to read, speak, and understand English - If subjects are currently taking medication for reflux or GERD, they much be on a stable does for at least 4 weeks prior to consent. Exclusion Criteria: - Patients who do not meet all inclusion criteria - Pregnant females

Study Design


Locations

Country Name City State
United States National Jewish Health Denver Colorado

Sponsors (1)

Lead Sponsor Collaborator
National Jewish Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The supraglottic index (SGI) quantifies laryngopharyngeal reflux (LPF) and is associated with severity of pulmonary fibrosis. Correlation between the supraglottic index and forced vital capacity. The supraglottic index is an index derived by assigning scores for edema and erythema of five supraglottic structures (epiglottis, false cords, arytenoids, posterior commissure, piriform recess) as viewed through a fiber-optic scope. Scores range from 0-22, with higher scores indicating more severe LPR. 6 months
See also
  Status Clinical Trial Phase
Completed NCT01406210 - RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol N/A
Completed NCT01263626 - Cough Monitoring Study N/A
Completed NCT01154634 - Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects Phase 2
Recruiting NCT05629143 - Primary carE PPi dEprescRibing Trial Phase 4
Recruiting NCT05899491 - Role of ARMA in Selective Subset of Refractory GERD Patients. N/A
Active, not recruiting NCT02001727 - HEP-FYN 12-Years Follow-up N/A
Completed NCT00863161 - Renal Impairment Study Phase 1
Active, not recruiting NCT00161096 - On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication Phase 3
Not yet recruiting NCT05162079 - Protocol for the ESREFLUJO Study: Epidemiological Study of Heartburn and Gastroesophageal Reflux in Community Pharmacy
Completed NCT00519441 - Do Patients Who Have Had Surgery for Achalasia Suffer From Reflux N/A
Completed NCT00175045 - Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis Phase 2
Terminated NCT04006002 - Mechanism of Weight Loss After Endoscopic and Laparoscopic Sleeve Procedures
Completed NCT02048449 - Inter-rater Reliability of the Reflux Finding Score Among Gastroenterologists N/A
Completed NCT00842387 - Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD) N/A
Unknown status NCT00216788 - The Effect of Nexium on Transmucosal Esophageal Leak Phase 1
Completed NCT01509352 - Prospective Randomized Trial Evaluating the Utility of Esophageal Stitches During Laparoscopic Fundoplication N/A
Completed NCT04329000 - On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus. N/A
Enrolling by invitation NCT05041608 - Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study
Completed NCT02226484 - Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? Phase 1
Completed NCT00687245 - Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD) Phase 1